These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27545142)

  • 1. Drug-induced hair colour changes.
    Ricci F; De Simone C; Del Regno L; Peris K
    Eur J Dermatol; 2016 Dec; 26(6):531-536. PubMed ID: 27545142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced hair colour changes.
    Bublin JG; Thompson DF
    J Clin Pharm Ther; 1992 Oct; 17(5):297-302. PubMed ID: 1464633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced hair disorders.
    Piraccini BM; Iorizzo M; Rech G; Tosti A
    Curr Drug Saf; 2006 Aug; 1(3):301-5. PubMed ID: 18690941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of repigmentation and curling of hair on acitretin therapy.
    Ward PD; Miller HL; Shipman AR
    Clin Exp Dermatol; 2014 Jan; 39(1):91-2. PubMed ID: 24266744
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid hair depigmentation in patient treated with pazopanib.
    Šeparović R; Pavlović M; Silovski T; Tečić Vuger A
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30139781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adverse drug reactions on hair].
    Gollnick H; Blume U; Orfanos CE
    Z Hautkr; 1990 Dec; 65(12):1128-34. PubMed ID: 2087842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repigmentation and curling of hair after acitretin therapy.
    Seckin D; Yildiz A
    Australas J Dermatol; 2009 Aug; 50(3):214-6. PubMed ID: 19659987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal hair].
    Coen M; Cramer B; Serratrice J
    Rev Med Interne; 2019 Feb; 40(2):134-135. PubMed ID: 29054584
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen-induced hair colour change.
    Hampson JP; Donnelly A; Lewis-Jones MS; Pye JK
    Br J Dermatol; 1995 Mar; 132(3):483-4. PubMed ID: 7718473
    [No Abstract]   [Full Text] [Related]  

  • 10. Hair graying and loss induced by imatinib mesylate.
    Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J
    J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled corticosteroid-induced hair depigmentation in a child.
    Bezzina C; Bondon-Guitton E; Montastruc JL
    J Drugs Dermatol; 2013 Jan; 12(1):119-20. PubMed ID: 23377340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma.
    Dika E; Patrizi A; Ribero S; Fanti PA; Starace M; Melotti B; Sperandi F; Piraccini BM
    Eur J Dermatol; 2016 Jun; 26(3):232-9. PubMed ID: 27019511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reactions affecting hair: diagnosis.
    Tosti A; Pazzaglia M
    Dermatol Clin; 2007 Apr; 25(2):223-31, vii. PubMed ID: 17430759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A-induced hair darkening.
    Rebora A; Delmonte S; Parodi A
    Int J Dermatol; 1999 Mar; 38(3):229-30. PubMed ID: 10208625
    [No Abstract]   [Full Text] [Related]  

  • 15. Hair cosmetics: dyes.
    Guerra-Tapia A; Gonzalez-Guerra E
    Actas Dermosifiliogr; 2014 Nov; 105(9):833-9. PubMed ID: 24656996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent hair growth during treatment with the EGFR inhibitor erlotinib.
    Alexandrescu DT; Kauffman CL; Dasanu CA
    Dermatol Online J; 2009 Mar; 15(3):4. PubMed ID: 19379648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible hair depigmentation in a patient treated with imatinib.
    Mariani S; Abruzzese E; Basciani S; Fiore D; Persichetti A; Watanabe M; Spera G; Gnessi L
    Leuk Res; 2011 Jun; 35(6):e64-6. PubMed ID: 21176848
    [No Abstract]   [Full Text] [Related]  

  • 18. [Memory resides in the hair].
    Füeßl HS
    MMW Fortschr Med; 2015 May; 157(10):36. PubMed ID: 26019089
    [No Abstract]   [Full Text] [Related]  

  • 19. Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.
    Sun A; Akin RS; Cobos E; Smith J
    J Drugs Dermatol; 2009 Apr; 8(4):395-8. PubMed ID: 19363859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Green hair].
    Petzoldt D; Braun-Falco M
    Hautarzt; 1995 Apr; 46(4):276. PubMed ID: 7790196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.